Trial Profile
A single-center, open-label, two-part, one-sequence crossover study to investigate the effect of cyclosporine and rifampicin on the pharmacokinetics of macitentan in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Aug 2014
Price :
$35
*
At a glance
- Drugs Macitentan (Primary) ; Ciclosporin; Rifampicin
- Indications Atopic dermatitis; Eisenmenger complex; Glioblastoma; Idiopathic pulmonary fibrosis; Psoriasis; Pulmonary arterial hypertension; Rheumatoid arthritis; Skin ulcer; Transplant rejection; Ulcerative colitis
- Focus Pharmacokinetics
- Sponsors Actelion Pharmaceuticals
- 14 Aug 2014 New trial record